Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATOS Atossa Genetics Inc

交易中 04-30 15:46:00 EDT

0.8863

+0.0908

+11.41%

最高0.8947	最低0.7900	成交量91.34万
今开0.7900	昨收0.7955	日振幅13.16%
总市值1.14亿	流通市值1.14亿	总股本1.29亿
成交额78.19万	换手率0.71%	流通股本1.29亿
市净率1.60	ROE-31.39%	每股收益-0.20
52周最高1.81	52周最低0.5526	市盈率-4.37
股息0.00	股息收益率0.00	ROA-19.99%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATOS","market":"US","secType":"STK","nameCN":"Atossa Genetics Inc","latestPrice":0.8863,"timestamp":1746042353016,"preClose":0.7955,"halted":0,"volume":913349,"delay":0,"floatShares":129109733,"shares":129170004,"eps":-0.202639,"marketStatus":"交易中","change":0.0908,"latestTime":"04-30 15:45:55 EDT","open":0.79,"high":0.8947,"low":0.79,"amount":781929.039088,"amplitude":0.131615,"askPrice":0.8864,"askSize":1157,"bidPrice":0.8863,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.202639,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1352350800000,"exchange":"NASDAQ","adjPreClose":0.7955,"preHourTrading":{"tag":"盘前","latestPrice":0.7932,"preClose":0.7955,"latestTime":"09:22 EDT","volume":3989,"amount":3283.64607225,"timestamp":1746019378388},"postHourTrading":{"tag":"盘后","latestPrice":0.7955,"preClose":0.7955,"latestTime":"19:09 EDT","volume":30892,"amount":24569.8575,"timestamp":1745968170067},"volumeRatio":1.372478,"impliedVol":1.0156,"impliedVolPercentile":0.636},"requestUrl":"/m/hq/s/ATOS","defaultTab":"news","newsList":[{"id":"2531769247","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.01%报0.780美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531769247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531769247?lang=zh_cn&edition=full","pubTime":"2025-04-30 00:44","pubTimestamp":1745945078,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日00时44分，Atossa Therapeutics, Inc.股票出现波动，股价大幅上涨5.01%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kala Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃，换手率分别为162.75%、152.07%、107.12%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为134.52%、54.29%、50.68%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学领域未满足的医疗需求领域开发专有药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043000443894e7d197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043000443894e7d197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","BK4007","LENZ","BK4139","ATOS"],"gpt_icon":0},{"id":"2529338935","title":"Atossa Therapeutics, Inc.盘中异动 急速上涨5.09%报0.655美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529338935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529338935?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:50","pubTimestamp":1745254221,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日00时50分，Atossa Therapeutics, Inc.股票出现波动，股价快速拉升5.09%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该信息摘要如下：Ascendiant Capital：维持Atossa Therapeutics评级，由买入调整至买入评级, 目标价由7.00美元调整至7.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042200502194dd1187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042200502194dd1187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOS","ATOWW","BK4007","LENZ"],"gpt_icon":0},{"id":"2529760808","title":"Ascendiant Capital：维持Atossa Therapeutics评级，由买入调整至买入评级, 目标价由7.00美元调整至7.25美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529760808","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529760808?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:14","pubTimestamp":1745230490,"startTime":"0","endTime":"0","summary":"Ascendiant Capital：维持Atossa Therapeutics(ATOS.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至7.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421181643973f45b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421181643973f45b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","LENZ"],"gpt_icon":0},{"id":"2516654003","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654003?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:34","pubTimestamp":1741026843,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时34分，Atossa Therapeutics, Inc.股票出现异动，股价大幅下挫5.21%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4397.62%、193.93%、179.44%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023403a25d852a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023403a25d852a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","BK4139","ATOS","LENZ"],"gpt_icon":0},{"id":"2513212909","title":"Atossa Therapeutics, Inc.盘中异动 临近收盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513212909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513212909?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:45","pubTimestamp":1740170707,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时45分，Atossa Therapeutics, Inc.股票出现波动，股价快速跳水5.35%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044508962bc94e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044508962bc94e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATOWW","ATOS"],"gpt_icon":0},{"id":"2512442484","title":"Atossa Therapeutics, Inc.盘中异动 临近午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512442484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512442484?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:35","pubTimestamp":1739982914,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时35分，Atossa Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为588.87%、244.87%、198.65%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003514a24c12c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003514a24c12c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","LENZ","BK4139"],"gpt_icon":0},{"id":"2511834577","title":"Atossa Therapeutics, Inc.盘中异动 临近收盘股价大涨5.98%报0.815美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511834577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511834577?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:49","pubTimestamp":1739479792,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时49分，Atossa Therapeutics, Inc.股票出现异动，股价快速上涨5.98%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214044952988475a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214044952988475a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","LENZ","ATOS"],"gpt_icon":0},{"id":"2510570356","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.82%报0.772美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510570356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510570356?lang=zh_cn&edition=full","pubTime":"2025-02-12 03:19","pubTimestamp":1739301549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日03时19分，Atossa Therapeutics, Inc.股票出现异动，股价急速跳水5.82%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.82%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120319099881eb56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120319099881eb56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOS","ATOWW","BK4139"],"gpt_icon":0},{"id":"2510377899","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.06%报0.804美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510377899?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:47","pubTimestamp":1739213269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时47分，Atossa Therapeutics, Inc.股票出现异动，股价大幅上涨5.06%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211024749abc9dc2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211024749abc9dc2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOWW","BK4139","ATOS"],"gpt_icon":0},{"id":"2509977520","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.22%报0.763美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509977520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509977520?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:04","pubTimestamp":1738958641,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时04分，Atossa Therapeutics, Inc.股票出现波动，股价快速下跌5.22%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040401abc66ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040401abc66ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","LENZ","BK4139"],"gpt_icon":0},{"id":"2509206797","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.00%报0.807美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509206797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509206797?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:39","pubTimestamp":1738859962,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时39分，Atossa Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5854.40%、1533.54%、155.27%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003922a23be9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003922a23be9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2508528457","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508528457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508528457?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:40","pubTimestamp":1738680045,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时40分，Atossa Therapeutics, Inc.股票出现异动，股价大幅拉升5.05%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1122.89%、764.82%、194.18%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Azitra Inc、Invivyd, Inc.，振幅分别为40.00%、38.71%、21.70%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224045a2392ab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224045a2392ab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","LENZ","ATOS"],"gpt_icon":0},{"id":"2507851961","title":"Atossa Therapeutics, Inc.盘中异动 大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507851961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507851961?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:39","pubTimestamp":1738334368,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时39分，Atossa Therapeutics, Inc.股票出现异动，股价急速拉升5.17%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1472.14%、334.79%、66.84%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Cyclerion Therapeutics, Inc.，振幅分别为62.40%、42.27%、32.28%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223928a23543c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223928a23543c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ATOS","ATOWW"],"gpt_icon":0},{"id":"2507830621","title":"Atossa Therapeutics, Inc.股价重挫12.03% 市值跌1135.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507830621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507830621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247477,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分，Atossa Therapeutics, Inc.股票出现异动，股价急速跳水12.03%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为583.70%、118.42%、93.09%，振幅较大的相关个股有Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Alterity Therapeutics Limited，振幅分别为17.92%、15.36%、10.65%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223117a23454d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223117a23454d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","LENZ","BK4139"],"gpt_icon":0},{"id":"2506308418","title":"Atossa Therapeutics, Inc.盘中异动 急速下跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506308418?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988372,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Atossa Therapeutics, Inc.股票出现异动，股价快速下跌5.51%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Akero Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、89Bio, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为720.20%、41.56%、37.50%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Evaxion Biotech As、Tevogen Bio Holdings Inc.，振幅分别为37.50%、14.26%、14.07%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232529874af6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232529874af6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOS","LENZ","ATOWW"],"gpt_icon":0},{"id":"2505729074","title":"Atossa Therapeutics, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505729074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505729074?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:52","pubTimestamp":1737557523,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时52分，Atossa Therapeutics, Inc.股票出现异动，股价快速拉升5.17%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Immunoprecise Antibodies Ltd.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为634.09%、129.40%、58.64%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Scisparc Ltd.，振幅分别为47.48%、41.27%、26.07%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225203986f7b74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225203986f7b74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","BK4139","LENZ"],"gpt_icon":0},{"id":"2505076742","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505076742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505076742?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:14","pubTimestamp":1737483250,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时14分，Atossa Therapeutics, Inc.股票出现波动，股价大幅拉升5.18%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.31%。其相关个股中，Camp4 Therapeutics Corporation、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为803.02%、514.11%、189.39%，振幅较大的相关个股有Channel Therapeutics Corporation、Camp4 Therapeutics Corporation、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为96.32%、46.97%、43.18%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122021410abb3766a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122021410abb3766a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATOWW","ATOS"],"gpt_icon":0},{"id":"2503685074","title":"Atossa Therapeutics, Inc.盘中异动 下午盘股价大跌5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503685074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503685074?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:00","pubTimestamp":1736884801,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时00分，Atossa Therapeutics, Inc.股票出现波动，股价大幅跳水5.72%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504000198663800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504000198663800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","LENZ","BK4139","ATOWW"],"gpt_icon":0},{"id":"2500142591","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500142591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500142591?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:44","pubTimestamp":1735915444,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时44分，Atossa Therapeutics, Inc.股票出现异动，股价快速拉升6.24%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1013.42%、778.01%、271.37%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为121.56%、76.84%、50.62%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224404a2146be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224404a2146be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","BK4139","LENZ"],"gpt_icon":0},{"id":"2500649481","title":"Atossa Therapeutics, Inc.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500649481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500649481?lang=zh_cn&edition=full","pubTime":"2025-01-01 03:05","pubTimestamp":1735671925,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日03时05分，Atossa Therapeutics, Inc.股票出现波动，股价快速下跌5.01%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010103052595f464ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010103052595f464ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atossatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1991},{"period":"1month","weight":0.1426},{"period":"3month","weight":-0.067},{"period":"6month","weight":-0.4236},{"period":"1year","weight":-0.4801},{"period":"ytd","weight":-0.1574}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atossa Therapeutics, Inc.于2009年4月30日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于在肿瘤学和传染病的重大未满足医疗需求领域发现和开发创新药物，目前专注于乳腺癌，其他乳房状况和COVID-19。他们正在开发的治疗乳腺癌和其他乳腺疾病的药物是Endoxifen，主要在两种情况下开发：一种是在乳腺癌诊断和手术之间的“机会窗口”中降低乳腺癌患者的肿瘤细胞活性；另一种适用于乳房组织致密的女性，以降低密度。他们正在开发的两种COVID-19药物是AT-H201，用于通过吸入改善中度至重度住院COVID-19患者的肺功能；和AT-301，一种供COVID-19患者在家使用的鼻腔喷雾剂。他们的业务战略是通过包括合作伙伴在内的临床研究来推进他们的项目，并通过收购、合作或内部开发机会性地在未满足的医疗需求领域增加项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.293861},{"month":2,"riseRate":0.538462,"avgChangeRate":0.099322},{"month":3,"riseRate":0.384615,"avgChangeRate":0.084638},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.054845},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.004454},{"month":6,"riseRate":0.583333,"avgChangeRate":0.133936},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.118738},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.056265},{"month":9,"riseRate":0.25,"avgChangeRate":-0.036311},{"month":10,"riseRate":0.083333,"avgChangeRate":-0.201299},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.048676},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.116498}],"exchange":"NASDAQ","name":"Atossa Genetics Inc","nameEN":"Atossa Genetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atossa Genetics Inc(ATOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atossa Genetics Inc,ATOS,Atossa Genetics Inc股票,Atossa Genetics Inc股票老虎,Atossa Genetics Inc股票老虎国际,Atossa Genetics Inc行情,Atossa Genetics Inc股票行情,Atossa Genetics Inc股价,Atossa Genetics Inc股市,Atossa Genetics Inc股票价格,Atossa Genetics Inc股票交易,Atossa Genetics Inc股票购买,Atossa Genetics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atossa Genetics Inc(ATOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atossa Genetics Inc(ATOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}